Download PDF
Thromb Haemost 1989; 61(01): 101-105
DOI: 10.1055/s-0038-1646535
Original Article
Schattauer GmbH Stuttgart

Studies of the Factor Xa-Dependent Inhibitor of Factor VIIa/Tissue Factor (Extrinsic Pathway Inhibitor) from Cell Supernates of Cultured Human Umbilical Vein Endothelial Cells

Bonnie J Warn-Cramer
The Departments of Medicine and Pathology University of California at San Diego, La Jolla, California, USA
,
Fanny E Almus
The Departments of Medicine and Pathology University of California at San Diego, La Jolla, California, USA
,
Samuel I Rapaport
The Departments of Medicine and Pathology University of California at San Diego, La Jolla, California, USA
› Author Affiliations
Further Information

Publication History

Received 06 June 1988

Accepted after revision 21 September 1988

Publication Date:
24 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

Cultured human umbilical vein endothelial cells (HUVEC) have been reported to produce extrinsic pathway inhibitor (EPI), the factor Xa-dependent inhibitor of factor VHa/tissue factor (TF). We examined the release of this inhibitor from HUVEC as a function of their growth state and in response to the induction of endothelial cell TF activity. HUVEC constitutively produced significant amounts of EPI at all stages of their growth in culture including the post-confluent state. Rate of release varied over a 3-fold range for primary cultures from 12 different batches of pooled umbilical cord cells. Constitutive EPI release was unaltered during a 6 hour period of induction of TF activity with thrombin or phorbol ester but slowed during longer incubation of the cells with phorbol ester. Whereas plasma contains two molecular weight forms of EPI, only the higher of these two molecular weight forms was demonstrable by Western analysis of HUVEC supernatants with 125I-factor Xa as the ligand.

Keywords

Extrinsic pathway inhibitor - Tissue factor - Factor VIIa - Factor Xa - Human endothelium
 

  • References

  • 1 Sanders NL, Bajaj SP, Zivelin A, Rapaport SI. Inhibition of tissue factor/factor VIIa activity in plasma requires factor X and an additional plasma component. Blood 1985; 66: 204-212
    PubMedGoogle Scholar
  • 2 Rao LV M, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood 1987; 69: 645-651
    PubMedGoogle Scholar
  • 3 Broze Jr GJ, Miletich JP. Characterization of the inhibition of tissue factor in serum. Blood 1987; 69: 150-155
    PubMedGoogle Scholar
  • 4 Broze Jr GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insights into its possible mechanism of action. Blood 1988; 71: 335-343
    PubMedGoogle Scholar
  • 5 Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze Jr GJ. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three Kunitz- type inhibitory domains. J Biol Chem 1988; 263: 6001-6004
    PubMedGoogle Scholar
  • 6 Broze Jr GJ, Miletich JP. Isolation of the tissue factor inhibitor produced by Hep G2 hepatoma cells. Proc Natl Acad Sci USA 1987; 84: 1886-1890
    CrossrefPubMedGoogle Scholar
  • 7 Bajaj MS, Rana SV, Wysolmerski RB, Bajaj SP. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease. J Clin Invest 1987; 79: 1874-1878
    CrossrefPubMedGoogle Scholar
  • 8 Rana SV, Reimers HJ, Pathikonda MS, Bajaj SP. Expression of tissue factor and factor VIIa/tissue factor inhibitor activity in endotoxin or phorbol stimulated U937 monocytelike cells. Blood 1988; 71: 256-262
    PubMedGoogle Scholar
  • 9 Balconi G, Dejana E. Cultivation of endothelial cells: Limitations and perspectives. Med Biology 1986; 64: 231-245
    PubMedGoogle Scholar
  • 10 Rao LV M, Bajaj SP. Purification of human factor VII utilizing O-(Diethylaminoethyl)-Sephadex and Sulfopropyl Sephadex chromatography. Anal Biochem 1984; 136: 357-361
    CrossrefPubMedGoogle Scholar
  • 11 Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981; 11: 397-412
    PubMedGoogle Scholar
  • 12 Usharani P, Wam-Cramer BJ, Kasper CK, Bajaj SP. Characterization of three abnormal factor IX variants (Bm Lake Elsinore, Long Beach, and Los Angeles) of hemophilia-B. J Clin Invest 1985; 75: 76-83
    CrossrefPubMedGoogle Scholar
  • 13 Rao LV M, Rapaport SI. Affinity purification of human brain tissue factor utilizing factor VII bound to immobilized anti-factor VII. Anal Biochem 1987; 165: 365-370
    CrossrefPubMedGoogle Scholar
  • 14 Wam-Cramer BJ, Maki SL, Zivelin A, Rapaport SI. Partial purification and characterization of extrinsic pathway inhibitor (the factor Xa-dependent plasma inhibitor of factor VIIa/tissue factor). Thromb Res 1987; 48: 11-22
    CrossrefPubMedGoogle Scholar
  • 15 Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745-2756
    CrossrefPubMedGoogle Scholar
  • 16 Almus FE, Rao LV M, Rapaport SI. Decreased inducibility of tissue factor activity on human umbilical vein endothelial cells cultured with endothelial cell growth factor and heparin. Thromb Res 1988; 50: 339-344
    CrossrefPubMedGoogle Scholar
  • 17 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685
    CrossrefPubMedGoogle Scholar
  • 18 Jaffe EA. Cell biology of endothelial cells. Hum Pathol 1987; 18: 234-239
    CrossrefPubMedGoogle Scholar
  • 19 Warr TA, Wam-Cramer BJ, Rao LV M, Rapaport SI. Physiologic variation in extrinsic pathway inhibitor. Arteriosclerosis 1988; 8: 681a
    PubMedGoogle Scholar
  • 20 Brox JH, Østerud B, Bjorklid E, Fenton II JW. Production and availability of thromboplastin in endothelial cells. The effects of thrombin, endotoxin and platelets Br J Haematol 1984; 57: 239-246
    CrossrefPubMedGoogle Scholar
  • 21 Gaidai KS. Thromboplastin synthesis in endothelial cells. Haemostasis 1984; 14: 378-385
    PubMedGoogle Scholar
  • 22 Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
    CrossrefPubMedGoogle Scholar